Don R Finley
age ~77
from Greenwood, IN
- Also known as:
-
- Don A Finley
- Dan R Finley
- Phone and address:
-
4644 Macy Dr, Greenwood, IN 46142
317 881-0514
Don Finley Phones & Addresses
- 4644 Macy Dr, Greenwood, IN 46142 • 317 881-0514
- Leesburg, IN
- Ann Arbor, MI
- Indianapolis, IN
- W Lafayette, IN
- West Lafayette, IN
Work
-
Position:Clerical/White Collar
Education
-
Degree:Associate degree or higher
Emails
License Records
Don Jose' Finley
License #:
47510 - Expired
Category:
Nursing Support
Issued Date:
Mar 11, 2002
Effective Date:
Mar 21, 2005
Expiration Date:
Mar 11, 2005
Type:
Medication Aide
Resumes
Owner
view sourceWork:
Pool & Spa Etc
Owner
Owner
Athletic Director
view sourceWork:
Skowhegan Area High School - Skowhegan, Me since Sep 1981
Athletic Director
Athletic Director
Don Finley
view source
Don Finley
view source
Don Finley
view source
Don Finley
view source
Don Finley
view source
Don Finley
view sourceIsbn (Books And Publications)
-
Mad Dogs: The New Rabies Plague
view source -
Author:Don Finley
-
ISBN #:0890968047
-
Mad Dogs: The New Rabies Plague
view source -
Author:Don Finley
-
ISBN #:0890968225
Us Patents
-
3-Substituted Oxindole Β-3 Agonists
view source -
US Patent:6911463, Jun 28, 2005
-
Filed:Aug 6, 2002
-
Appl. No.:10/486508
-
Inventors:Daniel Jon Sall - Greenwood IN, US
Jolie Anne Bastian - Beech Grove IN, US
Cynthia Darshini Jesudason - Indianapolis IN, US
Theo Schotten - Vierhufen, DE
Gerd Reuhter - Hamburg, DE
Don Richard Finley - Greenwood IN, US
Freddie Craig Stevens - Indianapolis IN, US
Vincent Patrick Rocco - Indianapolis IN, US
Patrick Gianpietro Spinazze - Avon IN, US
John Xiaoqiang He - Fishers IN, US
John Arnold Werner - Indianapolis IN, US
William George Trankle - Southport IN, US
Andrew Michael Ratz - Indianapolis IN, US -
Assignee:Eli Lilly and Company - Indianapolis IN
-
International Classification:A61K031/4035
A61K031/4196
A61K031/425
C07D209/44
C07D209/54 -
US Classification:514409, 51425409, 514278, 514323, 514381, 514383, 544230, 544333, 546 15, 546198, 5462777, 548146, 548147, 548181, 548250, 5482664, 548407, 548411, 548508
-
Abstract:The present invention relates to a β3 adrenergic receptor agonist of formula (I); or a pharmaceutical salt thereof; which is capable of increasing lipolysis and energy expenditure in cells and, therefore, is useful for treating Type 2 diabetes and/or obesity.
-
2-Oxo-Benzimidazolyl Substituted Ethanolamine Derivatives And Their Use As Βagonists
view source -
US Patent:7009060, Mar 7, 2006
-
Filed:Dec 24, 2002
-
Appl. No.:10/498261
-
Inventors:Cynthia Darshini Jesudason - Indianapolis IN, US
Don Richard Finley - Greenwood IN, US -
Assignee:Eli Lilly and Company - Indianapolis IN
-
International Classification:C07D 235/24
-
US Classification:5483064, 564305
-
Abstract:The present invention relates to a βadrenergic receptor agonist of formula I: or a pharmaceutical salt thereof; which is capable of increasing lipolysis and energy expenditure in cells and, therefore, is useful for treating Type 2 diabetes and/or obesity.
-
3-Substituted Oxindole Β3 Agonists
view source -
US Patent:7087635, Aug 8, 2006
-
Filed:Mar 16, 2005
-
Appl. No.:11/082106
-
Inventors:Daniel Jon Sall - Greenwood IN, US
Jolie Anne Bastian - Beech Grove IN, US
Cynthia Darshini Jesudason - Indianapolis IN, US
Don Richard Finley - Greenwood IN, US
Freddie Craig Stevens - Indianapolis IN, US
Vincent Patrick Rocco - Indianapolis IN, US
Patrick Gianpietro Spinazze - Avon IN, US
John Xiaoqiang He - Fishers IN, US
John Arnold Werner - Indianapolis IN, US
William George Trankle - Souhtport IN, US
Andrew Michael Ratz - Indianapolis IN, US
Theo Schotten - Vierhufen, DE
Gerd Reuhter - Hamburg, DE -
Assignee:Eli Lilly and Company - Indianapolis IN
-
International Classification:A61K 31/40
A61K 31/38
C07D 209/54
C07D 317/08
C07D 409/00 -
US Classification:514409, 514444, 514469, 548408, 549 59, 549228, 549229
-
Abstract:The present invention relates to a β3 adrenergic receptor agonist of formula I:.
-
Β3 Adrenergic Agonists
view source -
US Patent:7208505, Apr 24, 2007
-
Filed:Aug 6, 2002
-
Appl. No.:10/486867
-
Inventors:Daniel Jon Sall - Greenwood IN, US
Jolie Anne Bastian - Beech Grove IN, US
Rushad Eruch Karanjawala - Zionsville IN, US
Cynthia Darshini Jesudason - Indianapolis IN, US
Theo Schotten - Vierhufen, DE
Britta Evers - Hamburg, DE
Gerd Reuhter - Hamburg, DE
Don Richard Finley - Greenwood IN, US
Freddie Craig Stevens - Indianapolis IN, US
Vincent Patrick Rocco - Indianapolis IN, US
Patrick Gianpietro Spinazze - Avon IN, US
John Xiaoqiang He - Fishers IN, US
John Arnold Werner - Indianapolis IN, US
William George Trankle - Southport IN, US
Andrew Michael Ratz - Greenwood IN, US -
Assignee:Eli Lilly and Company - Indianapolis IN
-
International Classification:C07D 209/14
C07D 213/64
A61K 31/404
A61K 31/422
A61K 31/444 -
US Classification:514339, 514365, 514374, 514381, 514414, 5462774, 548235, 548252, 548467
-
Abstract:The present invention relates to a β3 adrenergic receptor agonist of formula (I); or a pharmaceutical salt thereof; which is capable of increasing lipolysis and energy expenditure in cells and, therefore, is useful, e. g. , for treating Type 2 diabetes and/or obesity.
-
2-Oxo-Benzimidazolyl Substituted Ethanolamine Derivatives And Their Use As Βagonists
view source -
US Patent:7214697, May 8, 2007
-
Filed:Sep 16, 2005
-
Appl. No.:11/228620
-
Inventors:Cynthia Darshini Jesudason - Indianapolis IN, US
Don Richard Finley - Greenwood IN, US -
Assignee:Eli Lilly and Company - Indianapolis IN
-
International Classification:A61K 31/4184
C07D 213/82 -
US Classification:514394, 5483064
-
Abstract:The present invention relates to a βadrenergic receptor agonist of formula (I), wherein R is C–Calkyl or (C–Ccycloalkyl)C–Calk-di-yl: Ris H, CN, halo; C–Calkyl, C–Chaloalkyl, COR, CONRR, NRCOR, NRR, OR, SR, SOR, S0Ror SONRR; Ris H, halo or C–Calkyl; Ris H or C–Calkyl; Rand Rare independently H or C–Calkyl Ris hydrogen, optionally substituted phenyl or optionally substituted heterocycle; X is absent or is OCHor SCH; Xis absent or C–Calk-di-yl; and Xis absent or is O, S, NH, NHSO, SONH or CH; or a pharmaceutical salt thereof; which is capable of increasing lipolysis and energy expenditure in cells and, therefore, is useful for treating Type 2 diabetes and/or obesity.
-
Histamine H3 Receptor Agents, Preparation And Therapeutic Uses
view source -
US Patent:7705025, Apr 27, 2010
-
Filed:Aug 15, 2005
-
Appl. No.:11/574044
-
Inventors:Don Richard Finley - Greenwood IN, US
Terry Patrick Finn - Geneva, CH
Philip Arthur Hipskind - New Palestine IN, US
William Joseph Hornback - Fishers IN, US
Cynthia Darshini Jesudason - Indianapolis IN, US
Takako Takakuwa - Indianapolis IN, US -
Assignee:Eli Lilly and Company - Indianapolis IN
-
International Classification:A61K 31/427
C07D 277/20 -
US Classification:514365, 548200, 548202, 548204
-
Abstract:The present invention provides a novel compound of Formula (I) or a pharmaceutically acceptable salt thereof, having histamine-H3 receptor antagonist or inverse agonist activity, as well as methods for preparing such compounds. In another, embodiment, the invention discloses pharmaceutical compositions comprising compounds of Formula (I) as well as methods of using them to treat obesity, cognitive deficiencies, narcolepsy, and other histamine H3 receptor-related diseases.
-
Pyrrolidine Derivatives As Histamine H3 Receptor Antagonists
view source -
US Patent:7951826, May 31, 2011
-
Filed:Mar 13, 2006
-
Appl. No.:11/908501
-
Inventors:Lisa Selsam Beavers - Franklin IN, US
Don Richard Finley - Greenwood IN, US
Robert Alan Gadski - Indianapolis IN, US
Philip Arthur Hipskind - New Palestine IN, US
Cynthia Darshini Jesudason - Indianapolis IN, US
Richard Todd Pickard - Noblesville IN, US
Freddie Craig Stevens - Indianapolis IN, US
Takako Takakuwa - Indianapolis IN, US -
Assignee:Eli Lilly and Company - Indianapolis IN
-
International Classification:A61K 31/4439
A61K 31/4025
C07D 401/14
C07D 403/06 -
US Classification:514343, 514422, 5462791, 548518
-
Abstract:The present invention discloses novel compounds of Formula (I) or pharmaceutically acceptable salts thereof which have histamine-H3 receptor antagonist or inverse agonist activity, as well as methods and intermediates for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising compounds of Formula (I) as well as methods of using them to treat obesity, cognitive deficiencies, narcolepsy, and other histamine H3 receptor-related diseases.
-
Histamine H3 Receptor Agents, Preparation And Therapeutic Uses
view source -
US Patent:8008296, Aug 30, 2011
-
Filed:Jun 28, 2006
-
Appl. No.:11/917941
-
Inventors:Lisa Selsam Beavers - Franklin IN, US
Don Richard Finley - Greenwood IN, US
Robert Alan Gadski - Indianapolis IN, US
Philip Arthur Hipskind - New Palestine IN, US
William Joseph Hornback - Fishers IN, US
Cynthia Darshini Jesudason - Indianapolis IN, US
Richard Todd Pickard - Noblesville IN, US
Takako Takakuwa - Indianapolis IN, US
Grant Mathews Vaught - Indianapolis IN, US -
Assignee:Eli Lilly and Company - Indianapolis IN
-
International Classification:A61K 31/535
A61K 31/497
A61K 31/445
C07D 413/00
C07D 409/00
C07D 207/00 -
US Classification:5142355, 51425401, 514326, 514422, 544141, 544372, 546208, 548523
-
Abstract:The present invention discloses novel compounds of Formula I or pharmaceutically acceptable salts thereof which have histamine-H3 receptor antagonist or inverse agonist activity, as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising compounds of Formula I as well as methods of using them to treat obesity, cognitive deficiencies, narcolepsy, and other histamine H3 receptor-related diseases. (Formula I).
Googleplus
Don Finley
Don Finley
Don Finley
Don Finley
Youtube
News
Finding a way to fund higher education
view source- as only one [public] institution that was taking tuition-fee dollars and putting it into student aid. That was the University of Virginia, which was the first to do it, says Don Finley, a former state secretary of education who now is president of the Virginia Business Higher Education Council. Tw
- Date: Oct 27, 2011
- Category: U.S.
- Source: Google
Plaxo
Don Finley
view sourceWest Chester, PA, United States
Don Finley
view sourceDallas, TX
Don Finley
view sourceVice President Franchise Development at Accor Nort...
Don Finley
view source
Don Finley
view source
Don Finley
view source
Don Finley
view source
Don Finley
view source
Don Finley
view source
Don Finley
view source
Don Finley
view sourceMyspace
Classmates
Don Finley
view sourceSchools:
Skowhegan High School Skowhegan ME 1962-1966
Community:
Scott Langley, Gloria Steward
Don Finley
view sourceSchools:
Booker T. Washington High School Houston TX 1967-1971
Community:
Margienell Sanford, Bruce Jeffero, Andrew Keys, Brandy Baltimore
Don Finley
view sourceSchools:
La Salle High School Cincinnati OH 1969-1973
Community:
Thomas Sweeney
Don Finley (Same As Aboive)
view sourceSchools:
Freeport High School Freeport TX 1946-1950
Community:
Joseph Pessarra, Barbara Lyle, Jim Bailey
Don Finley
view sourceSchools:
Elkmont High School Elkmont AL 1953-1957
Community:
Frances Reno, Rose Wolfe
Don Finley, Stark High Sc...
view source
Centennial Secondary High...
view sourceGraduates:
Don Finley (1974-1978),
Sandi Daudlin Farina (1982-1986),
Evie Bourguignon (2007-2011),
Shelley Finley (1982-1986)
Sandi Daudlin Farina (1982-1986),
Evie Bourguignon (2007-2011),
Shelley Finley (1982-1986)
Elkmont High School, Elkm...
view sourceGraduates:
Tallie Hardiman (1971-1975),
Amelia Gatlin (1991-1995),
Don Finley (1953-1957),
Georgia Campbell (1952-1956),
Brandi Farmer (1998-2002)
Amelia Gatlin (1991-1995),
Don Finley (1953-1957),
Georgia Campbell (1952-1956),
Brandi Farmer (1998-2002)
Flickr
Get Report for Don R Finley from Greenwood, IN, age ~77